UK fines Pfizer, Flynn Pharma USD 84 million for overcharging NHS Ruchika Sharma22 July 2022 2:22 PM ISTEpanutin is a life-saving drug which is used to control a variety of epileptic conditions, or prevent seizures during or after brain surgery or severe...
Pfizer, BioNTech submit variation to EMA for vaccination of children 6 months to less than 5 years with COMIRNATY Ruchika Sharma11 July 2022 4:27 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the companies have submitted a variation to the European Medicines Agency...
Pfizer-BioNTech gets USFDA nod for COVID vaccine Comirnaty for adolescents 12 through 15 years of age Ruchika Sharma9 July 2022 1:45 PM ISTCOMIRNATY (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute...
USFDA authorizes pharmacists to prescribe Pfizer COVID drug Paxlovid Ruchika Sharma8 July 2022 2:30 PM ISTThe agency said patients who tested positive for COVID-19 should bring their health records for the pharmacists to review for kidney and liver...
COVID vaccine: BioNTech faces patent lawsuit in Germany over use of MRNA technology Ruchika Sharma6 July 2022 5:00 PM ISTCureVac said that it was not seeking an injunction, nor intended to take legal action that would impede the production, sale or distribution of the...
German health minister in move to boost COVID drug Paxlovid use Ruchika Sharma4 July 2022 12:58 PM ISTThe pill, which won conditional European marketing approval in January, is given to infected people who are at high risk of progression to severe...
Pfizer seeks USFDA nod for COVID drug Paxlovid for high-risk patients Ruchika Sharma2 July 2022 11:55 AM ISTPAXLOVID is a SARS-CoV-2 main protease (Mpro) inhibitor (also known as SARS-CoV-2 3CL protease inhibitor) therapy.
Pfizer-BioNTech omicron-adapted COVID vaccines demonstrate high immune response Ruchika Sharma27 Jun 2022 4:30 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Pfizer sets sights on elimination of blinding disease trachoma by 2030 Ruchika Sharma26 Jun 2022 9:00 AM ISTThe ITI had initially hoped to eliminate the disease by 2020, but is now setting its sights on 2030.
Pfizer sued for patent infringement over Paxlovid Roshni Dhar25 Jun 2022 5:30 PM ISTPfizer Inc's blockbuster COVID-19 treatment Paxlovid violates an Enanta Pharmaceuticals Inc patent for its COVID drug still in development, according...
Health Bulletin 25/June/2022 Roshni Dhar25 Jun 2022 4:34 PM ISTHere are the top health stories for the day:Every harm, intimidation, obstruction or hindrance to healthcare professionals is violence: Kerala...
Pfizer sued for patent infringement over COVID-19 drug Paxlovid Ruchika Sharma24 Jun 2022 12:35 PM ISTEnanta requested an unspecified amount of money damages from Pfizer, including royalties.
